Dang et al., 2001 - Google Patents
Combination bacteriolytic therapy for the treatment of experimental tumorsDang et al., 2001
View HTML- Document ID
- 7609826575854133351
- Author
- Dang L
- Bettegowda C
- Huso D
- Kinzler K
- Vogelstein B
- Publication year
- Publication venue
- Proceedings of the National Academy of Sciences
External Links
Snippet
Current chemotherapeutic approaches for cancer are in part limited by the inability of drugs to destroy neoplastic cells within poorly vascularized compartments of tumors. We have here systematically assessed anaerobic bacteria for their capacity to grow expansively within …
- 206010028980 Neoplasm 0 title abstract description 124
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Dang et al. | Combination bacteriolytic therapy for the treatment of experimental tumors | |
| US7344710B2 (en) | Combination bacteriolytic therapy for the treatment of tumors | |
| Zhou et al. | Tumour-targeting bacteria engineered to fight cancer | |
| Agrawal et al. | Bacteriolytic therapy can generate a potent immune response against experimental tumors | |
| Bhatt et al. | Targeted inhibition of gut bacterial β-glucuronidase activity enhances anticancer drug efficacy | |
| Lopez et al. | Microbiota effects on carcinogenesis: initiation, promotion, and progression | |
| Staedtke et al. | Clostridium novyi-NT in cancer therapy | |
| Büttner et al. | Bacterial endosymbionts protect beneficial soil fungus from nematode attack | |
| Ingham et al. | Mutually facilitated dispersal between the nonmotile fungus Aspergillus fumigatus and the swarming bacterium Paenibacillus vortex | |
| Staib et al. | Differential activation of a Candida albicans virulence gene family during infection | |
| Guruge et al. | Epithelial attachment alters the outcome of Helicobacter pylori infection | |
| El‐Hassan et al. | Formulation and delivery of the bacterial antagonist Bacillus subtilis for management of lentil vascular wilt caused by Fusarium oxysporum f. sp. lentis | |
| Li et al. | Exploring the modulatory effects of gut microbiota in anti-cancer therapy | |
| Tannock | A special fondness for lactobacilli | |
| Barbé et al. | The use of clostridial spores for cancer treatment | |
| Rosenberg et al. | Antitumor effects in mice of the intravenous injection of attenuated Salmonella typhimurium | |
| O’Mahony et al. | Differential cytokine response from dendritic cells to commensal and pathogenic bacteria in different lymphoid compartments in humans | |
| Bridier et al. | Spatial organization plasticity as an adaptive driver of surface microbial communities | |
| Wang et al. | Learning from Clostridium novyi-NT: how to defeat cancer | |
| Park et al. | Pathogenesis of Streptoverticillium albireticuli on Caenorhabditis elegans and its antagonism to soil‐borne fungal pathogens | |
| Campbell et al. | Effect of bentonite clay on the growth of Gaeumannomyces graminis var. tritici and on its interactions with antagonistic bacteria | |
| Keyhani et al. | Effect of extracellular vesicles of Lactobacillus rhamnosus GG on the expression of CEA gene and protein released by colorectal cancer cells | |
| Boulanger et al. | Helenalin reduces Staphylococcus aureus infection in vitro and in vivo | |
| Palace et al. | Gain-of-function analysis reveals important virulence roles for the Yersinia pestis type III secretion system effectors YopJ, YopT, and YpkA | |
| Hoffman | The preclinical discovery of bacterial therapy for the treatment of metastatic cancer with unique advantages |